Summary
Background Effective management of acne vulgaris in primary care involves support (usually provided over a number of consultations) and prescription of effective treatments. However, consulting and prescribing patterns for acne in primary care are not well described. Objectives To describe the rate of primary-care consultations and follow-up consultations; prescribing patterns, including overall use of acne-related medications (ARMs); and initial and follow-up prescription for acne vulgaris in the U.K. Methods U.K. primary-care acne consultations and prescriptions for ARMs were identified in the Clinical Practice Research Datalink. Annual consultation rates (between 2004 and 2013) by age and sex, new consultations and consultations in the subsequent year were calculated, along with prescribing trends -during a new consultation and over the subsequent 90 days and year -using the number of registered patients as the denominator. Results Two-thirds (66Á1%) of patients who had a new acne consultation had no further acne consultations in the subsequent year. Overall 26Á7%, 24Á9%, and 23Á6% and 2Á8% of patients were prescribed no ARM, an oral antibiotic, a topical antibiotic or an oral plus topical antibiotic, respectively, during a new acne consultation. In total 60Á1% and 38Á6% of patients prescribed an ARM received no further ARM prescriptions in the following 90 days and 1 year, respectively, despite most prescriptions being for 2 months or less. Prescribing rates for lymecycline and topical combined clindamycin and benzoyl peroxide increased substantially between 2004 and 2013. There were no important changes in consultation rates between 2004 and 2013. Conclusions These data suggest that patients with acne are receiving a suboptimal initial choice of ARMs, longitudinal care and prescribing.
What's already known about this topic?
• Most patients with acne self-manage or are managed in primary care.
• Studies suggest low consultation rates and medication adherence for acne.
• Longitudinal care with follow-up appointments could improve medication use and outcomes.
• Oral and topical antibiotic use can promote the development of antimicrobial resistance.
What does this study add?
• Two-thirds of patients who have a new acne consultation have no follow-up consultation during the subsequent year.
• Oral antibiotics are the most common acne-related medications (ARMs) prescribed, normally without coprescribing topical nonantibiotic agents.
• Following an initial prescription, 60Á1% and 38Á6% of patients received no further ARM prescriptions in the following 90 days and 1 year, respectively. Acne vulgaris ('acne' hereafter) is one of the most common dermatological conditions managed by health services in the developed world. 1 It has a significant impact on quality of life 2, 3 and is associated with mental health problems and suicide. 1, 4 Acne is a chronic condition that usually begins in the early teens and is present in over 40% of those in their thirties. 5 In the U.K., most medical care for people with acne is provided in primary care. Acne can be treated effectively with a range of antibiotic and nonantibiotic approaches. However, for medications to be effective they need to be used regularly. Little is known about how frequently acne medications are initiated, and, once started, for how long they are used. Most of these medications have a slow onset of action and need to be used for several weeks or months before full effectiveness is seen. Therefore, it is important to ensure that patients receive adequate information about use of the medication, and ideally monitoring and support to encourage ongoing use (for at least 3-4 months). Guidance for clinicians recommends close monitoring and follow-up appointments. 6, 7 Consulting in primary care for acne allows (i) for accurate diagnosis and assessment of severity; (ii) an opportunity to discuss the evidence for the effectiveness of various treatments, to seek the patient's ideas and expectations, to dispel myths and come to a shared decision regarding a treatment plan; and (iii) for education about the slow onset of action of most acne medications and the need for prolonged treatment. Early follow-up consultations are recommended by U.K. guidelines 6 and are important in order to provide ongoing support and encourage regular use of medication, to monitor for adverse effects and to provide advice about changes to treatment regimens where necessary, and to monitor for adverse psychological impacts. However, it is not clear how often patients consult in primary care, in terms of both new consultations and follow-up consultations. In addition, there are few data about the medications that primary-care clinicians prescribe for acne and how frequently they are prescribed to an individual patient. There are increasing concerns about the development of antibiotic resistance in acne, and U.K. guidelines recommend restricting antibiotics to second-or third-line treatments and combining oral antibiotics with topical treatments such as benzoyl peroxide (to reduce resistance), or retinoids or adapalene (to reduced comedones). [6] [7] [8] We set out to determine the rates and trends in primary-care consultations for acne, and the frequency of subsequent (follow-up) acne consultations in patients having a new (index) consultation for acne. In addition, we aimed to determine which medications are prescribed in primary care for acne, how these have changed, and the patterns of prescribing during the year following an index consultation. (Table S1 ; see Supporting Information). We excluded unusual codes such as acne fulminans, chlorine acne, iodine acne and colloid acne. We also excluded children aged < 8 years and codes for acne neonatorum and infantile acne, as prepubertal acne is uncommon and usually noninflammatory, and we excluded those with no sex identified in the data. At each consultation point, patients were classified into one of four age bands (8-11 years, 12-18 years, 19-29 years and ≥ 30 years). We did not restrict on the basis of recorded consultation type (i.e. surgery consultation, telephone consultation, home visit). CPRD undertake data quality checks and flag patients as having acceptable data or not. For all analyses, and for calculating denominators, we used only patients who had been flagged as having acceptable data.
Patients and methods

Consultation rates
Age-and sex-specific consultation rates per 1000 person-years were calculated using age-and sex-specific denominators calculated based on patients registered with CPRD practices during the same time period. The number of registered patients during each month was averaged over each study year. Annual age-and sex-specific rates were plotted for 2004-2013, and average annual rates were tabulated.
In order better to describe acne consultation patterns following an initial consultation, we identified a cohort of patients with an 'index' acne consultation occurring between 2005 and 2012, no acne consultations and no primary-care prescriptions for acne-related medications (ARMs) in the year prior to their index consultation, and at least 1 year of follow-up data available after their index consultation (patients who died or transferred to a different surgery during their follow-up year were excluded). We then followed each patient for the year following their index consultation and counted the number of subsequent acne consultations, and the time to first subsequent acne consultation, for each participant.
Prescribing
Prescribing was assessed by examining the following as ARMs based on guidance in the British National Formulary: oral oxytetracycline, tetracycline, doxycycline, lymecycline, minocycline and erythromycin; topical antibiotics (erythromycin or clindamycin); topical retinoid (and retinoidlike) preparations; topical benzoyl peroxide and azelaic acid; topical combination products; and co-cyprindiol. Prescriptions for oral antibiotics that were for < 28 days and erythromycin suspensions were excluded because these are less likely to have been prescribed for acne. Combined oral contraceptives other than co-cyprindiol can be used for treating acne, but were not included because they are commonly prescribed for contraception or menstrual problems and it is not possible using the CPRD data to determine whether they were being prescribed for acne or not. Relevant items were grouped together on the basis of their active ingredient(s). ARMs that were prescribed during the 10-year study period were identified for all patients who had one or more Read codes for acne at any point during the 10-year period, whether they occurred at the time of an acne consultation or not. Total annual ARM prescription rates were calculated and plotted for each ARM.
To describe further the pattern of ARM use, we used the cohort with an index consultation and at least 1 year of follow-up data available, as described earlier. We calculated the number and type of ARMs that were prescribed at the index consultation, during the subsequent 90 days, and during the subsequent year. We classified each ARM into one of the following four groups: topical antibiotic, topical nonantibiotic, oral antibiotic and co-cyprindiol. Consultations were then classified as involving prescription of one of the four groups described above or one of the following combinations: oral antibiotic + topical nonantibiotic, oral antibiotic + topical antibiotic, co-cyprindiol + any topical agent, and other combinations. Along with 'no ARM' this resulted in nine groups. We then identified the prescribing group for each index consultation and the changes in group (including to 'no ARM') during the subsequent 90 and 364 days. Prescribing at the index consultation and changes during the first 90 days were then plotted using a Sankey diagram in SankeyMATIC (http://sankeymatic.com). Finally, we identified the quantity of medication prescribed for each ARM, and described the median and interquartile range. Oral antibiotic prescriptions where the quantity prescribed was greater than 672 (equivalent to four times a day for 6 months) were excluded as these were thought likely to be errors.
This study was approved by the Independent Scientific Advisory Committee (references 14-095 and 14-096), the independent body that approves use of CPRD data. The study protocols and programming code can be made available on request. Stata statistical software version 13 (StataCorp, College Station, TX, U.S.A.) was used for all analyses.
Results
Consultation rates
In total 318 772 patients had been assigned a code for acne at some point during 2004-2013. We removed 230 (0Á07%) patients who had no consultations where they were aged ≥ 8 years and seven patients with missing data on sex, leaving 716 272 consultations in 318 535 patients. The highest consultation rates were found in 12-18-year-old girls, followed by 12-18-year-old boys, 19-29-year-old women and 19-29-year-old men (Table 1, Fig. 1 ). Consultation rates were low for 8-11 year olds and those aged ≥ 30 years. There did not appear to be any significant trends in consultation rates over the period from 2004 to 2013 (Fig. 1) .
Reconsultations
In total 167 573 patients aged ≥ 8 years met the criteria for inclusion in the cohort. Of these, 66Á1% had no further acne consultations during the following year, 21Á8% had one, and 12Á1% had two or more. Of those who did have a subsequent acne consultation during the following year, more than half (55Á5%) occurred after the first 90 days, and there was slightly less early follow-up in younger patients ( Table 2) . (Fig. 3) .
A total of 167 573 patients aged ≥ 8 years were identified as having a new acne consultation (index consultation), with no prior acne consultations or ARM prescriptions in the previous 12 months. Around one-quarter (26Á7%) of these were prescribed no ARM during their index consultation. The most common ARM prescribed during the index consultation was oral antibiotic alone (24Á9% of consultations). The frequencies of prescribing other ARM combinations at the index consultation are given in Table 3 . Overall, 67Á5% of patients were prescribed no ARMs during the 90 days following the index consultation. One-third of these (39 314) were not prescribed an ARM at the index consultation, and were also not prescribed an ARM in the following 90 days. Nearly half (20 481, 49Á0%) of those prescribed an oral antibiotic at the index consultation had no further ARM prescriptions in the following 90 days, and the majority of those prescribed topical antibiotics (27 670, 70Á0%) and topical nonantibiotics (15 926, 76Á3%) were prescribed no further ARMs in the following 90 days. Figure 4 gives a graphical representation of which ARMs (or combinations) patients were prescribed at baseline and in the following 90 days. In total 78 567 patients (46Á9%) were prescribed no ARMs during the year following their index The values are n (%).
consultation. Of the 122 764 patients who were prescribed an ARM at their index consultation, 73 817 (60Á1%) and 47 408 (38Á6%) were prescribed no further ARMs during the subsequent 90 days and 1 year, respectively. Very few patients were prescribed oral isotretinoin, either at the index consultation or during the following year. The quantity of ARMs per prescription was approximately equivalent to 2-3 months' worth for most patients (Table 4) .
Discussion
In this analysis of routinely collected U.K. general-practice data we found that consultation rates for acne in primary care are relatively low, and were largely stable between 2004 and 2013. Using population distribution data from 2013, our data suggest that there are around 934 000 general practitioner consultations for acne per year, and that a typical general practice of 7000 patients would expect to have 115 consultations for acne per year: one with 8-11 year olds, 25 with 12-18-year-old boys, 29 with 12-18-year-old girls, 13 with 19-29-year-old men, 28 with 19-29-year-old women, four with men aged ≥ 30 years and 15 with women aged ≥ 30 years.
Only one-third of patients who have a new acne consultation (no acne consultations or prescriptions in the preceding year) have a follow-up acne consultation in the subsequent year. One-quarter of patients with a new acne consultation are prescribed no ARMs during their initial consultation, twothirds receive no ARMs during the following 3 months (even though quantities prescribed are generally for < 3 months), and only about one-half receive one or more ARMs in the subsequent year. Oral antibiotics (without any prescribed topical medication) were the most common ARM to be prescribed at the first consultation, followed by topical medication Proportion of those who were prescribed an ARM. relatively low rates, but prescribing of the third-generation topical retinoid, adapalene (as a single agent), and combined adapalene and benzoyl peroxide increased from around 2010-2011 onwards.
Our study included a large representative sample and data from across England and Wales. We were able to use data for a 10-year period allowing for a description of consultation and prescribing rate trends over time. We were able to account for patients joining or leaving practices in our denominators, and this is significant as 29% of the patients consulting for acne transferred out of the practice before 2013, and 38% of the patients in our study joined the practice between 2004 and 2013. The CPRD uses data collected as part of routine clinical care, and therefore the data may not always be relevant for research purposes. We did not exclude on the basis of consultation type and therefore may have included some out-of-hours, secondary-care or spurious consultations as primary-care consultations. This is unlikely to have been a frequent occurrence, but our consultation rates and follow-up rates may be a slight overestimate of actual rates.
Prescribing data are well coded in U.K. primary care; however, prescriptions are not directly linked to a diagnosis (they are linked to a 'consultation', which may or may not have one or more diagnostic codes), and therefore we cannot be certain that all prescriptions were actually for acne. Most ARMs are fairly specific for acne, but oral antibiotics could have been prescribed for other indications. We dealt with this by identifying a cohort of patients with a 'new' acne consultation and at least 1 year of follow-up data, by following them over 1 year, and by including only prescriptions of oral antibiotics that were for ≥ 28 days. The Read code system used in U.K. primary care does not allow for coding of severity or site, and so we are not able to present data on this.
We excluded prescriptions for oral antibiotics that were for fewer than 28 tablets (equivalent to 7 days) and oral erythromycin suspensions, as most of these are unlikely to be for acne. However, it is possible that some of these prescriptions were for acne. Topical treatments containing benzoyl peroxide are available without a prescription in the U.K., so it is possible that some of the patients who appeared to be using 'no ARMs' were actually using over-the-counter benzoyl peroxide. Combined oral contraceptives are not licensed for use in acne in the U.K. (apart from co-cyprindiol, which is licensed for severe acne), but are known to be effective and are likely to have been prescribed for acne in some patients. However, U.K. primary-care data do not link indications to prescriptions, and therefore it is impossible to determine which combined oral contraceptives were prescribed for acne and which were not.
Our estimate of acne consultation rates suggests a total number of primary-care consultations (934 000) that is considerably lower than the 3Á5 million consultations per year that has been cited in a number of publications. [10] [11] [12] This number seems to have been extrapolated from data from a small (180 patients) French study of patients with severe acne, and therefore is unlikely to be representative of consulting behaviour for acne of all severities in the U.K. 13 Diagnoses are not always well recorded in primary-care data, 14 and follow-up consultations may use nonspecific codes like 'patient reviewed' instead of a diagnostic code. Therefore, our data may underestimate the true incidence of primary-care consultations for acne, and the follow-up rate following an initial consultation. However, Purdy et al. used similar primary-care data in their study, and they undertook a validation process that found no primary-care consultations for acne that had not been coded. 15 Therefore, it seems likely that our data represent the most accurate estimate of primary-care consultation rates for acne in the U.K. There are few reliable measurements of overall acne prevalence in the U.K., but if we use prevalence rates from the U.S.A. 16 we can calculate an estimated total U.K. prevalence of around 8Á1 million, suggesting that in any given year there is only one primary-care consultation for every eight to nine patients with acne. This seems broadly consistent with a study of schoolchildren that found that less than one-third of those with definite acne had ever consulted a doctor.
17
A previous retrospective cohort study examined acne incidence using primary-care records. The authors extracted data from 14 general practices in northeast England and reported an incidence of first consultations in 13-25 year olds over 12 months of 1Á6% (16 per 1000 person-years), and a period prevalence (over 12 months) of acne (defined as anyone consulting or receiving medication for acne) of 3Á1%. 15 Our consultation rates of 75Á2 and 92Á8 consultations per 1000 patient years for 12-18-year-old boys and girls, respectively, are clearly higher, but reflect total consultations rather than just first consultations. Our finding that the highest consultation rates are among teenagers is consistent with other studies, 15,18-20 but we were also able to demonstrate that a considerable number of patients aged ≥ 30 years (especially women) consult for acne. The same cohort study reported that in 2001-2002 just over 50% of male patients and one-third of female patients were prescribed oral antibiotics first line, between one-third and one-quarter of male and female patients were prescribed nonantibiotic topical ARMs first line, and about 20% of male patients and one-quarter of female patients were prescribed topical antibiotics first line. 15 The proportion who were prescribed more than one medication was not described in this study, but the data are compatible with our finding that a large proportion of patients are treated with oral antibiotics first line. We have not been able to identify any other studies looking at follow-up consultations and ongoing prescribing; however, an international cross-sectional survey of patients attending a follow-up appointment (1-3 months after a preceding acne consultation) identified that 58% of patients in Europe had poor adherence to acne medication. 21 The natural history of acne is not well described, as there is a lack of high-quality prospective cohort studies. However, acne is largely considered to be a chronic condition, with cross-sectional studies showing onset in the teenage years and persistence into the thirties of forties for many patients. 1 As acne is a chronic condition, and especially one where medication can take weeks or months to achieve maximal effect, 22 and myths and misperceptions are common, 23 ongoing care
in the form of follow-up appointments is important. National Institute for Health and Care Excellence (NICE) clinical knowledge summaries (CKS) guidance suggests that patients should be reviewed after 6-8 weeks to assess treatment response and provide support. 6 Therefore, our finding that two-thirds of patients have no follow-up consultations in the subsequent year, and that the majority of those that do consult do so > 3 months after their initial consultation (which is longer than the typical duration of treatment prescribed), suggests that longitudinal acne care may be suboptimal in primary care. Some patients may have had mild acne and just wanted reassurance, and others may have been happy to use over-the-counter treatment and have no follow-up. Without data on severity it is not possible to determine the proportion falling into this category, but as three-quarters of new acne consultations involved prescribing an ARM and around one-third of those were prescriptions for oral antibiotics, the numbers are unlikely to be high. Some may have been referred on to secondary care, and this may explain their lack of follow-up in primary care. We did not extract data on referrals, but Purdy et al. reported that only 8Á5% of patients were referred over a 2-year follow-up period, 15 so referral is unlikely to account for a large proportion of the patients who had no follow-up. Furthermore, we found that 60% of patients who are started on one or more ARMs were not prescribed any further ARMs in the subsequent 90 days. It is possible that some of these patients had a rapid resolution, and others may have moved on to using over-the-counter products; however, these data suggest that a large proportion discontinued or poorly adhered to treatment before giving it sufficient opportunity to work. General practitioners have been encouraged to limit the use of antibiotics, and this may have contributed to the short duration of oral antibiotic prescribing. However, most guidance suggests that antibiotic treatment should be for at least 3-4 months, 24 and that maintenance therapy with topical nonantibiotic treatments should be continued or initiated after oral antibiotics are stopped. Our data suggest limited use of prescription nonantibiotic treatments, either as single agents or in combination with oral antibiotics. Around one-third of patients with a new acne consultation who were treated with an ARM were prescribed only an oral antibiotic, a further third were prescribed only a topical antibiotic, and another 11% were prescribed both an oral antibiotic and a topical agent. Therefore, in total, just over three-quarters of initial acne therapy included an antibiotic. NICE CKS guidance for moderate acne recommends considering oral antibiotics only when there is extensive or difficultto-reach acne on the back or when there is a significant risk of scarring or pigment change, and indicates that they should be combined with topical nonantibiotics. 6 We do not know the severity, extent or location of the acne in this study, and we do not know how many patients were using topical agents that they purchased over the counter. Nevertheless, these data suggest significant overuse of antibiotics in general and underuse of topical nonantibiotic treatment in those prescribed oral antibiotics. This is an important concern, given the increasing prevalence of resistant Propionibacterium acnes, 8 and the effects of antibiotic use for acne on resistance in other commensals 25 and the development of respiratory-tract infections. 26 Our finding that oral tetracyclines were the most commonly prescribed oral antibiotics is consistent with guidance. 6 There is good-quality evidence supporting the use of benzoyl peroxide and topical retinoid alone or combined with a topical antibiotic, and these agents are recommended in guidelines. 6, 7 Benzoyl peroxide is an effective antimicrobial, but does not promote the development of resistance, and topical retinoids play an important role in acne management because of their role in preventing comedogenesis. The increasing use of topical combined clindamycin and benzoyl peroxide is therefore consistent with the evidence, but the low use of topical retinoid and benzoyl peroxide that we found is concerning. Again, we have no information about how many of these patients were using topical agents purchased over the counter, but our data do suggest significant underuse of these agents.
In conclusion, our data suggest that the management of acne in primary care is suboptimal and that consultation rates are relatively low for such a common condition. Management is over-reliant on antibiotic treatment (especially oral antibiotics) and underutilizes nonantibiotic treatment. Oral antibiotics are frequently prescribed and in most cases they are prescribed without concurrent topical nonantibiotic treatments (increasing the risk of resistance and in contravention to guidelines). Treatment courses are too short, and follow up is less than optimal. Interventions to improve the management of acne in primary care need to be urgently developed and evaluated.
